Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01032785
Other study ID # 0049-09-WOMC
Secondary ID
Status Recruiting
Phase N/A
First received December 15, 2009
Last updated September 12, 2010
Start date December 2009
Est. completion date March 2010

Study information

Verified date September 2010
Source Wolfson Medical Center
Contact Akiva Tamir, M.D.
Email tamir@wolfson.health.gov.il
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Observational

Clinical Trial Summary

It is known that the foramen ovale closes in most infants during the first 6 months of life, however, most of the important papers in the field concentrated on observing infants with murmurs and following those with patent foramen ovale by echocardiography until 6-24 months. The purpose of this study is to observe the natural profile of closure of the foramen ovale and ductus arteriosus for the first 36 hours after birth. This understanding may help to avoid unnecessary treatment and exams for newborns with findings that are natural for their stage of development.


Description:

We will observe the patency and size of foramen ovale five times within the first 36 hours of life. We will also describe the anatomy of the foramen ovale and the septum primum during this time. The direction of flow across the foramen ovale will also be observed. Other cardiac lesions will be checked for as well. We will measure the change in size of the pulmonary arteries and the closure of the ductus arteriosus.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 4 Hours
Eligibility Inclusion Criteria:

- any baby born in term and with normal delivery

Exclusion Criteria:

- sick newborns in need of neonatal intensive care for any medical reason.

- newborns with congenital heart disease except for small, muscular ventricular septal defects

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
no interventions
no interventions

Locations

Country Name City State
Israel Wolfson Medical Center Holon

Sponsors (1)

Lead Sponsor Collaborator
Wolfson Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patent Foramen Ovale size using 2 echocardiography positions, shunt direction and distance of septum primum to Superior Vena Cava 2-3 hours after birth, 5-6 hours, 7-8 hours, 12-13 hours and 36 hours No
Secondary Patent Ductus Arteriosus size, shunt direction and the size of the Left Pulmonary Artery, the Right Pulmonary Artery and the Pulmonary Annulus 2-3 hours after birth, 5-6 hours, 7-8 hours, 12-13 hours, 36 hours No